STOCK TITAN

Globus Med Stock Price, News & Analysis

GMED NYSE

Company Description

Company Overview

Globus Medical Inc (GMED) is a pioneer in the development of advanced musculoskeletal solutions and spinal surgery technologies, dedicated to addressing unmet clinical needs in orthopedic and spinal procedures. With a foundation built on superior engineering and innovative design, the company has established itself as a leading medical device manufacturer focused on transforming patient care through cutting-edge products.

Core Business and Product Innovation

At the heart of Globus Medical’s operations is its dual focus on musculoskeletal solutions and enabling technologies. The musculoskeletal segment features a comprehensive suite of implants and surgical instruments primarily used in spinal and orthopedic procedures. These products are designed to enhance the precision and efficiency of surgeries, ensuring that surgeons have access to the latest advancements in technology. The enabling technologies segment encompasses advanced computer systems, robotic navigation platforms, and surgical aids that contribute to improved clinical outcomes and procedural accuracy.

The company has been at the forefront of integrating robotics into the surgical environment. Its innovative robotic navigation systems have received regulatory clearances, demonstrating the firm’s commitment to not only precision but also usability in high-demand clinical settings. The integration of such systems into clinical practice is a testament to Globus Medical’s dedication to enhancing surgical workflows and improving patient outcomes.

Market Position and Competitive Advantage

Globus Medical has secured its position in the competitive landscape of the medical device industry through a strong emphasis on technological innovation and clinical support. The company differentiates itself by:

  • Focusing on comprehensive, state-of-the-art solutions that combine implants with advanced surgical navigation systems.
  • Employing robust engineering practices to ensure the durability and precision of its products.
  • Delivering superior clinical education and support that enhances surgeon proficiency and operational efficiency.

Its strategic emphasis on continuous product development and regulatory compliance enables the company to maintain a competitive edge while meeting the complex demands of modern surgical practices.

Commitment to Clinical Excellence

Globus Medical’s relentless pursuit of innovation is intertwined with its commitment to clinical excellence. The company invests significantly in research and development to bring forward state-of-the-art solutions that address diverse clinical challenges. Its product portfolio not only provides effective musculoskeletal solutions but also includes enabling technologies that enhance the operational capabilities of modern surgical suites. This multi-faceted approach ensures that every aspect of the company’s offering is designed with patient outcomes and surgical precision in mind.

Furthermore, Globus Medical works closely with clinical experts to tailor its solutions to the evolving needs of spinal surgery and orthopedic procedures. This collaboration fosters an environment of continuous learning and innovation, ensuring that the company remains at the forefront of technological advancements while delivering products that are both reliable and effective.

Significance in the Industry

Operating in a challenging and fast-evolving sector, Globus Medical stands out through its focused approach and commitment to quality. Its products are integral to many surgical procedures across both domestic and international markets, reinforcing its role as a key player in the musculoskeletal and spinal surgery domains. The company’s advancements in robotic navigation and implant technology not only contribute to operational excellence in surgical environments but also drive improvements in patient outcomes across a wide range of clinical settings.

Globus Medical Inc continues to leverage its deep domain expertise and innovative spirit to offer robust, reliable and clinically effective solutions. By aligning cutting-edge technology with direct clinical applications, the company has solidified its reputation as an authoritative source in medical devices, underpinning its ongoing impact on the future of surgical care.

Stock Performance

$—
0.00%
0.00
Last updated:
55.59 %
Performance 1 year
$9.8B
Market Cap
137.5M
Shares outstanding

SEC Filings

No SEC filings available for Globus Med.

Financial Highlights

$2,519,355,000
Revenue (TTM)
$102,984,000
Net Income (TTM)
$0.75
Diluted EPS (TTM)
$520,638,000
Operating Cash Flow
4.09%
Net Profit Margin
6.59%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Globus Med (GMED)?

The current stock price of Globus Med (GMED) is $73.07 as of April 24, 2025.

What is the market cap of Globus Med (GMED)?

The market cap of Globus Med (GMED) is approximately 9.8B.

What is the revenue (TTM) of Globus Med (GMED) stock?

The trailing twelve months (TTM) revenue of Globus Med (GMED) is $2,519,355,000.

What is the net income of Globus Med (GMED)?

The trailing twelve months (TTM) net income of Globus Med (GMED) is $102,984,000.

What is the earnings per share (EPS) of Globus Med (GMED)?

The diluted earnings per share (EPS) of Globus Med (GMED) is $0.75 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Globus Med (GMED)?

The operating cash flow of Globus Med (GMED) is $520,638,000.

What is the profit margin of Globus Med (GMED)?

The net profit margin of Globus Med (GMED) is 4.09%.

What is the operating margin of Globus Med (GMED)?

The operating profit margin of Globus Med (GMED) is 6.59%.

What is the gross margin of Globus Med (GMED)?

The gross profit margin of Globus Med (GMED) is 58.90%.

What is the current ratio of Globus Med (GMED)?

The current ratio of Globus Med (GMED) is 2.54, indicating the company's ability to pay short-term obligations.

What is the gross profit of Globus Med (GMED)?

The gross profit of Globus Med (GMED) is $1,483,876,000 on a trailing twelve months (TTM) basis.

What is the operating income of Globus Med (GMED)?

The operating income of Globus Med (GMED) is $165,991,000.

What does Globus Medical Inc specialize in?

Globus Medical Inc specializes in developing advanced musculoskeletal solutions and spinal surgery technologies, offering both implants and enabling surgical innovations.

What are the primary product segments of the company?

The company focuses on two key segments: musculoskeletal solutions, which include spinal and orthopedic implants and instruments, and enabling technologies that enhance surgical precision.

How does Globus Medical generate its revenue?

Revenue is primarily generated through direct sales of its medical devices to hospitals, physicians, and surgical centers, particularly in the musculoskeletal and orthopedic domains.

What differentiates Globus Medical from its competitors?

Globus Medical is distinguished by its strong emphasis on technological innovation, particularly in robotic navigation systems and integrated enabling technologies that improve surgical outcomes.

Which markets does Globus Medical serve?

The company serves a broad range of markets, including domestic and international regions, providing innovative solutions for spinal and orthopedic procedures to hospitals and surgical centers.

How does the company ensure clinical excellence and reliability?

Through continual investment in R&D, active collaboration with clinical experts, and adherence to stringent regulatory standards, Globus Medical ensures that its products meet high clinical and operational benchmarks.

What role do enabling technologies play in Globus Medical's business model?

Enabling technologies support the company’s core product offerings by enhancing surgical navigation, improving procedural accuracy, and integrating advanced computer systems into clinical workflows.

How does Globus Medical support surgeon education and training?

The company provides comprehensive clinical support and education programs to ensure that surgeons are proficient in using its advanced technologies, thereby optimizing surgical outcomes and procedural efficiency.